Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 47,700 shares at $2.19 ($104K) on 2024-12-23, disclosed to the SEC on 2024-12-26.
Open-market purchase of $104k IMMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.17 | 7,700 | $17K | 16.0% |
| 2 | $2.19 | 40,000 | $88K | 84.0% |
| Total | $2.19 avg | 47,700 | $104K | 100% |
| Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |
| IMMX | BUY | 2023-09-12 | $25K | — | Filing → |